As of Feb 27
| +0.041 / +7.33%|
The 2 analysts offering 12-month price forecasts for InspireMD Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +566.67% increase from the last price of 0.60.
The current consensus among 2 polled investment analysts is to Buy stock in InspireMD Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.